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Abstract
Background: The choice of operation for tumours at or around the gastro-oesophageal junction
remains controversial with little evidence to support one technique over another. This study
examines the prevalence of margin involvement and nodal disease and their impact on outcome
following three surgical approaches (Ivor Lewis, transhiatal and left thoraco-laparotomy) for these
tumours.
Methods:  A retrospective analysis was conducted of patients undergoing surgery for distal
oesophageal and gastro-oesophageal junction tumours by a single surgeon over ten years.
Comparisons were undertaken in terms of tumour clearance, nodal yield, postoperative morbidity,
mortality, and median survival. All patients were followed up until death or the end of the data
collection (mean follow up 33.2 months).
Results: A total of 104 patients were operated on of which 102 underwent resection (98%).
Median age was 64.1 yrs (range 32.1–79.4) with 77 males and 25 females. Procedures included 29
Ivor Lewis, 31 transhiatal and 42 left-thoraco-laparotomies. Postoperative mortality was 2.9% and
median survival 23 months. Margin involvement was 24.1% (two distal, one proximal and 17
circumferential margins). Operative approach had no significant effect on nodal clearance, margin
involvement, postoperative mortality or morbidity and survival. Lymph node positive disease had a
significantly worse median survival of 15.8 months compared to 39.7 months for node negative (p
= 0.007), irrespective of approach.
Conclusion: Surgical approach had no effect on postoperative mortality, circumferential tumour,
nodal clearance or survival. This suggests that the choice of operative approach for tumours at the
gastro-oesophageal junction may be based on the individual patient and tumour location rather
than surgical dogma.
Background
Distal oesophageal and gastro-oesophageal junction
(GOJ) tumours now represent the commonest oesopha-
geal tumour type in many western countries [1]. GOJ
tumours are further classified as either lower third
oesophageal with GOJ involvement (Siewert type I), true
junctional (Siewert type II) or gastric cardia/fundal can-
cers with GOJ involvement (Siewert type III) [2]. In prac-
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tice the precise classification is difficult and this may pose
difficulties when deciding on the optimal surgical
approach. Although a transabdominal technique is appli-
cable to surgical resection of tumours of the gastric cardia/
fundus (Siewert type III), a number of different
approaches have been employed for surgical resection of
cancer of the distal oesophagus and Siewert type I and II
GOJ tumours.
It is claimed that the surgical approach used for these
tumours may influence the ability to obtain tumour clear-
ance and therefore impact upon survival. However, stud-
ies directly comparing different surgical approaches are
difficult to interpret and have yielded contradictory
results. The Ivor Lewis transthoracic and transhiatal
approaches have been compared in patients with
oesophageal cancer in terms of duration of procedure,
hospital stay, postoperative outcome and survival, with
no obvious benefit to either approach [3-8]. These studies
include three randomised controlled trials and show no
significant difference in rates of anastomotic leakage,
postoperative mortality or survival between the
approaches [4-6]. Only three studies have addressed spe-
cifically tumours of the distal oesophagus, GOJ and gas-
tric cardia, with only Sasako et al., noting a higher
morbidity in patients undergoing the left thoraco-laparot-
omy approach in comparison to transhiatal techniques
[8-10]. Population based figures from the Scottish Audit
of Gastric and Oesophageal Cancer (SAGOC), showed
that there was little difference in outcome between the
three commonest operative approaches for oesophageal
cancer i.e. transhiatal, Ivor Lewis and left thoraco-laparot-
omy [11].
Irrespective of the approach utilised, positive surgical
resection margins have been shown to adversely impact
upon loco-regional recurrence and long term survival in
oesophageal cancer patients [12-15]. Although achieving
adequate nodal clearance per se has not been shown to the
influence prognosis, the lymph node yield carries prog-
nostic information in the presence of node positive dis-
ease [4,7,16].
This study focuses on tumours of the distal oesophagus
and the gastro-oesophageal junction (Siewert types I and
II) which now represent the commonest tumour type in
western societies. It compares three surgical approaches in
terms of resection margin clearance, lymph node yield
and the prevalence of positive nodal disease and their
impact on outcome.
Methods
Data was collected prospectively and analysed retrospec-
tively on patients with oesophageal and gastro-oesopha-
geal (GOJ) tumours undergoing potentially curative
surgery between 1994 and 2003.
Tumour location
Analysis was focused on oesophageal tumours in the dis-
tal third of the oesophagus (>33 cm ab orum) and type I
and II tumours of the GOJ according to the Siewert classi-
fication [2]:
Type I tumours – adenocarcinoma of the distal oesopha-
gus with the bulk of the disease 1 to 5 cm above the GOJ,
arising from Barrett's epithelium
Type II tumours – true adenocarcinoma of the cardia aris-
ing from the cardiac epithelium or short segments with
intestinal metaplasia at the GOJ, with the bulk of tumour
1 cm above to 2 cm below the GOJ.
Clinical staging
All subjects were medically fit (ASA grade I – III, WHO
performance status ≤ 2) and underwent initial staging
consisting of endoscopy, chest radiograph and thoracic
and abdominal computerised tomography (CT) scan with
contrast. Abdominal ultrasound scanning was performed
to evaluate any abnormalities identified on the abdomi-
nal CT and a barium swallow performed if the endoscope
was unable to traverse the lesion. During the final year of
the study patients underwent endoscopic ultrasound as
part of the staging process. Staging laparoscopy was per-
formed to assess some type I and II tumours, based on
radiological findings and at the surgeons discretion. All
patients were discussed within the Upper Gastro-intesti-
nal Multi-Disciplinary Team meeting, consisting of oncol-
ogists, radiologists and surgeons with a sub-specialty
interest in gastro-oesophageal disease.
Surgery
Surgery was performed two to four weeks following the
completion of neo-adjuvant chemotherapy. During the
early study period, patients were randomised to receive
neo-adjuvant or no neo-adjuvant chemotherapy as part of
the OE02 trial, while latterly all patients received neo-
adjuvant chemotherapy based on the results of this trial
[17]. All but seven patients completed the two cycles of
chemotherapy.
One of three surgical approaches (Ivor Lewis, transhiatal
or left thoraco-laparotomy) was performed by a single
surgeon at a single institution. A gastric tube was formed
for the neo-oesophagus for all patients. A left thoraco-
laparotomy approach through the 8th intercostal space
was the operation of choice for GOJ tumours in the early
part of the study. This was gradually phased out and
replaced by a transhiatal approach during the studyWorld Journal of Surgical Oncology 2007, 5:95 http://www.wjso.com/content/5/1/95
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period and is now generally reserved for patients with
deep chests or who are obese.
The transhiatal approach was used selectively for tumours
less than 6 cm in length and when the whole tumour
could be dissected under direct vision from within the
abdomen after enlargement of the hiatus with a left sided
cervical anastomosis. Two patients were converted from
the transhiatal to Ivor Lewis approach during surgery.
Pathology
Pathological staging was performed according to the crite-
ria from the American Joint Committee on Cancer [18].
All tumours underwent complete macroscopic clearance
(R0/R1). Overall margin involvement included, either dis-
tal, proximal and/or circumferential resection margins
(CRM). Evidence of tumour 1 mm or less from any surface
was taken as a positive margin. The lymph node yield as
well as the number of tumour positive lymph nodes was
documented.
Follow up
All patients were followed up until death or the end of the
data collection (August 2004) with a mean follow up of
33.2 months. Documented postoperative morbidity
included anastomotic leak (based on clinical and/or radi-
ological evidence with all patients undergoing a water sol-
uble contrast swallow on the fifth post operative day),
chest infection/pneumonia (clinical and/or radiological
evidence) and cardiac complications (myocardial infarc-
tion/ischaemia or dysrythmias on electrocardiogram or
elevation in cardiac enzymes). Postoperative mortality
was defined as 30-day mortality. In hospital mortality is
also depicted.
Statistical analysis
Survival analysis was performed using Kaplan-Meier sur-
vival curves with comparisons drawn using log rank test.
Test of association used the Chi-squared statistic, Fishers
exact test (2-sided) or One Way ANOVA (Statistical Pack-
age for Social Sciences (SPSS) version 12.1). Statistical sig-
nificance was denoted by a p value of <0.05.
Results
Patient and tumour characteristics
104 patients with distal third oesophageal or type I/II GOJ
tumours underwent surgery within a 10 year period. Sur-
gical resection was possible in 102 patients (98%). In two
patients abdominal exploration identified more advanced
disease than had been evident on preoperative staging
precluding resectional surgery. There was no significant
difference in patient demographics between each of the
operative approaches used (table 1) with a median age of
Distribution of procedures over time Figure 1
Distribution of procedures over time.
Ivor Lewis
Transhiatal 
Left Thoraco-
laparotomy 
Table 1: Patient and tumour characteristics
Characteristic Ivor Lewis Transhiatal Left Thoraco-
laparotomy
p value
Number Resected 29 31 42
Median Age (years) 61.8 64.0 66.6 0.858
Male 20 23 34 0.503
Histology Adenocarcinoma 22 29 37 0.125
Squamous Cell 
Carcinoma
725
Stage I 5 6 0 0.013
I I A1 31 01 7 0 . 5 9 4
IIB 2 7 5 0.191
III 8 8 20 0.092
IVA 1 0 0 0.281
Tumour Location Oesophageal 21 12 13 0.002
GOJ 8 19 29
Neoadjuvant chemotherapy 11 15 17 0.686World Journal of Surgical Oncology 2007, 5:95 http://www.wjso.com/content/5/1/95
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64.1 years (range 32.1 – 79.4), with 77 males and 25
females. As expected, adenocarcinoma was the dominant
histological type with tumours at this location.
Tumour location and stage
46 (45%) tumours were located within the distal
oesophagus whilst 56 tumours were classified as GOJ
tumours. As expected, the Ivor Lewis approach was per-
formed more often for distal third oesophageal tumours
and transhiatal/left thoraco-laparotomy approach more
often for GOJ tumours (p = 0.002) (table 1). There were
significantly fewer stage I tumours within the left thoraco-
laparotomy group (p = 0.013) although the proportion of
stage I tumours was similar for both the Ivor Lewis and
transhiatal groups.
Treatment
There was no difference in the proportion of patients
receiving neo-adjuvant chemotherapy between each of
the operative approaches used as all patients were subject
to identical randomisation protocols for the OEO2 trial
(table 1). Figure 1 displays the distribution of each proce-
dure over the study period demonstrating a phased with-
drawal of the thoraco-laparotomy approach in favour of a
transhiatal technique.
Postoperative morbidity and mortality
Overall 53 patients (52%) suffered a significant postoper-
ative complication, the most common of which was chest
infection (31%), followed by cardiac events (11%) and
anastomotic leak (10%) (table 2). There was no statisti-
cally significant difference between the incidence of com-
plications and the different surgical approaches (p  =
0.864), although chest infections tended to occur more
frequently in patients undergoing an Ivor Lewis approach
and anastomotic leakage was more common in patients
with a neck anastomosis in the transhiatal approach. The
overall postoperative mortality was 2.9%, with similar
rates for each of the three techniques used (table 3). In
hospital mortality was 4.9%. Tumour location had no
impact on postoperative mortality.
Survival
Irrespective of the approach, the overall median survival
was 23 months, with a one and five year survival of 68%
and 20% respectively. The median survival for those
undergoing the Ivor Lewis, transhiatal and left thoraco-
laparotomy were 18, 44 and 17 months respectively (p =
0.395), with five year survival displayed in figure 2.
Tumour location had no impact on survival (table 3). The
use of neo-adjuvant chemotherapy had no significant
effect on five year survival, (figure 3). The study period
was analysed as an influential variable on survival and
was found to have no significant impact on five year sur-
vival, p = 0.442 (figure 4).
Lymph node yield
Comparisons of nodal yield and tumour margins were
based on 83 cases with full pathological data available (25
Ivor Lewis, 25 transhiatal and 33 left thoraco-laparot-
omy). The median number of resected nodes was similar
irrespective of the operative approach used, Ivor Lewis (9,
range 2–16), transhiatal (8, range 1–18) and left thoraco-
laparotomy (7, range 0–23) (p  = 0.285) (figure 5a).
Kaplan Meier five year survival curves by procedure Figure 2
Kaplan Meier five year survival curves by procedure.
Table 2: Postoperative morbidity by approach
Ivor Lewis n = 29 Transhiatal n = 31 Left Thoraco-laparotomy n 
= 42
p value
Chest Infection 12 (41%) 7 (23%) 13 (31%) 0.292
Cardiac Event 3 (10%) 2 (6%) 6 (14%) 0.564
Anastomotic Leak 1 (3%) 5 (16%) 4 (10%) 0.255World Journal of Surgical Oncology 2007, 5:95 http://www.wjso.com/content/5/1/95
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Tumour location had no effect on nodal yield (p = 0.898).
In those with full pathology data available (n = 83), 45
patients had one or more lymph nodes positive for
tumour. The median number of lymph nodes involved
were 0 (range 0–8), 1 (range 0–7) and 1 (range 0–13)
respectively for the Ivor Lewis, transhiatal and left tho-
raco-laparotomy approaches (figure 5b). Lymph node
positive tumours had a significantly reduced median sur-
vival of 15.8 months in comparison to 39.7 months for
lymph node negative tumours (p = 0.007) (figure 6).
Circumferential tumour margin
Overall margin involvement, including two distal, one
proximal and 17 circumferential margins (CRM), was
24.1% (20 of 83) with a positive CRM accounting for 85%
of these cases. There was no significant difference between
the three techniques in the prevalence of CRM involve-
ment (Ivor Lewis 5, transhiatal 6, left thoraco-laparotomy
6) (p = 0.860) (table 4). Tumour location had no impact
on CRM involvement (distal oesophageal 6, GOJ 11) (p =
0.451). Tumour T stage had a significant impact on CRM,
p = 0.005, with all apart from one (T2 tumour, Ivor Lewis)
CRM involvement occurring in T3–4 disease. Neo-adjuvant
chemotherapy did not affect CRM involvement (p  =
0.172).
There was no significant difference in the median survival
between overall (inclusive of circumferential, proximal
and distal resection margins) positive and negative resec-
tion margins of 17.4 and 23.4 months, respectively, (p =
0.836) irrespective of surgical approach used. Although
the difference in median survival of CRM positive patients
was worse, at 17.4 months compared to 32.8 months for
CRM negative tumours (figure 7), this did not reach statis-
tical significance (p = 0.195). Higher T staging lead to a
more likely positive CRM and therefore a trend effect on
survival (although not significant). This is intuitive and as
shown in our study in that all but one of the CRM posi-
tives occurred in higher T stage tumours. The one case of
a T2 tumour with a positive CRM was clearly a disappoint-
ing reflection of inadequate surgical clearance.
Discussion
The choice of operation for tumours at or around the gas-
tro-oesophageal junction remains controversial with little
evidence to support one technique over another. Indeed a
population based audit demonstrated a number of differ-
ent techniques used for oesophageal and gastro-oesopha-
geal cancers, the three most common being: Ivor Lewis
(30%), left thoraco-laparotomy (30%) and transhiatal
(15%) [11].
In this study we have compared these three approaches
undertaken by a single surgeon, over a 10 year period, so
eliminating inter-operator variability, which may be
greater than the differences between techniques per se, as
shown in previous surgical studies [19]. The reduction in
Kaplan Meier five year survival curves by neoadjuvant chem- otherapy Figure 3
Kaplan Meier five year survival curves by neoadjuvant chem-
otherapy.
Table 3: Postoperative mortality and survival
Procedure p value Tumour Location p value
Ivor Lewis n = 
29
Transhiatal n = 
31
Left Thoraco-
laparotomy n = 
42
Oesophageal n 
= 46
GOJ n = 56
Postoperative 
Mortality
210-21-
Median Survival 
(months)
18 44 17 0.395 33 22 0.530World Journal of Surgical Oncology 2007, 5:95 http://www.wjso.com/content/5/1/95
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the number of resections performed each year is explained
by the employment of a further two surgeons undertaking
oesophago-gastric cancer resections. The resections per-
formed by the other two surgeons were deliberately not
included in order to reduce inter-operator variability. This
was not a randomised trial but rather a pragmatic and
practical approach to tailor the operative technique to the
individual patient and tumour location and length. The
transhiatal approach was limited to tumours in which dis-
section could be performed under direct vision to beyond
the tumour and the Ivor Lewis technique applied to
longer and more proximally situated tumours. During the
study period, there was a deliberate and phased with-
drawal of the left thoraco-laparotomy approach which
was then reserved for patients with deeper chests or obes-
ity. The selection of surgical approach was therefore per-
formed on the basis of tumour length and location (i.e.
Ivor Lewis versus transhiatal/Left thoraco-laparotmy), and
not on the basis of stage.
The overall postoperative mortality in this series (2.9%)
compares favourably to population based figures [11] and
individual series comparing the three procedures [20-22].
Similarly, the one-year survival in this series was 68% with
a five-year survival of 20% (median survival was 23
months) which is similar to reported series [13]. Although
some reports have suggested a trend towards reduced long
term survival with the transhiatal approach, no significant
difference between the procedures in terms of disease free
survival have been reported. Furthermore these studies
have included patients with disease of the mid oesopha-
gus for which the transhiatal approach may not be appro-
priate [5,9]. In contrast this series found a trend towards
improved survival amongst the transhiatal resections. This
is likely to represent the selective approach employed
rather than any oncological advantage to the transhiatal
method of oesophagectomy.
We found in this series, as have others, that patients with
positive lymph nodes had a significantly worse prognosis
than lymph node negative patients [4,7]. The value of
extended lymphadenectomy in oesophageal cancer
remains controversial [5,23,24]. In this series the surgical
approach did not influence the number of lymph nodes
recovered and an en-bloc resection of a junctional tumour
is possible with each of the approaches used. Although the
number of harvested nodes remains low in this series
compared with others [5,7], three studies have also
reported a similar low node harvest [9,15,25] with Stark et
al., removing on average of 10.7 and 10.8 nodes for the
transhiatal and Ivor Lewis approaches, respectively [9].
The lymph node yield is not only reflective of the surgery,
but also of the pathological reporting systems. During the
study period, no clear guidelines existed in the United
Kingdom [26] as to the minimum number of nodes to be
assessed, in comparison with other consensus groups
[27], a possible explanation for the low lymph node yield.
Furthermore, there may have been relative under staging
due to the use of neo-adjuvant chemotherapy.
Influence of study period on five year survival Figure 4
Influence of study period on five year survival.
Table 4: Margin involvement
Resection Margin Procedure p value
Ivor Lewis Transhiatal Left Thoraco-
laparotomy
Overall Margins Clear 19 18 26 0.836
Margins Involved 6 7 7
Margins Involved Proximal 0 0 1 -
D i s t a l 110-
CRM 5 6 6 0.860World Journal of Surgical Oncology 2007, 5:95 http://www.wjso.com/content/5/1/95
Page 7 of 9
(page number not for citation purposes)
A postoperative complication occurred in 52% of patients
in this series, similar to that of national figures [11].
Although there was a trend towards a reduced incidence of
pulmonary complications with the transhiatal approach,
this did not reach statistical significance. A trend towards
an increased cervical anastomotic leak rate was noted in
transhiatal resections consistent with findings noted by
some [9,28] but not all studies [5,29].
Tumour clearance was similar with each approach used
with a positive CRM being present in 20.5% of cases, with
neo-adjuvant chemotherapy having no effect on CRM
involvement. This was lower than reported in the SAGOC
study with a 31% positive CRM [11]. As expected, tumour
T stage had a significant effect on circumferential tumour
clearance, with only one T2 tumour having a circumferen-
tial positive margin. This was a clearly disappointing
reflection of inadequate surgical clearance. Distribution of
tumour stage was only significantly skewed in stage I
tumours and as expected, this had no effect on the overall
proportion of positive resection margins. Reported rates
of CRM involvement in the literature vary from 7–47%
and as well as reflecting surgical technique, they may also
vary according to the definition of positive resection mar-
gins [3,12-14,30]. Higher rates have been reported when
a strict definition of any tumour within 1 mm of the mar-
gin is included. This was the definition used in this study
and in the SAGOC report where positive CRM patients
had a one year survival of 39% compared to 68% with a
negative CRM [11]. Furthermore, in a study comparing
gastrectomy to oesophagectomy for type II and III
tumours, Ito et al demonstrated margin involvement to be
an independent prognostic factor [15]. It is therefore
important that clear resection margins are achieved.
In this series, surgical approach did not alter margin
involvement which may be due to our selection process,
although it may be influenced by the small numbers. The
overall rate of positive CRM must be reduced and strate-
gies for doing so may include improved patient staging
and neoadjuvant therapy. The impact of endoscopic ultra-
sound in this situation is being investigated as part of a
major ongoing trial [31]. However, it is likely that surgical
philosophy may be equally if not more important with
surgery being reserved for patients in whom an R0 resec-
tion is most likely rather.
Conclusion
In this series, the surgical approach for distal oesophageal
and oesophago-gastric tumour resection had no effect on
postoperative mortality, survival, circumferential tumour
clearance or nodal yield. We suggest that the choice of
operative approach for tumours at or around the gastro-
oesophageal junction may be based upon the individual
patient and tumour location and length rather than surgi-
cal dogma.
Kaplan Meier five year survival curves by nodal involvement Figure 6
Kaplan Meier five year survival curves by nodal involvement.
Lymph nodes 5a: Lymph node yield, 5b: Number of involved  nodes by procedure Figure 5
Lymph nodes 5a: Lymph node yield, 5b: Number of involved 
nodes by procedure.
a) 
b) 
Ivor Lewis
Transhiatal 
Left Thoraco-
laparotomy 
Ivor Lewis
Transhiatal 
Left Thoraco-
laparotomy World Journal of Surgical Oncology 2007, 5:95 http://www.wjso.com/content/5/1/95
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